References
- Monnier VM, Elmets CA, Frank KE, Vishwanath V, YamashitaT. 1986. Age-related normalization of the browning rate of collagen in diabetic subjects without retinopathy.J Clin Invest 78: 832-835. https://doi.org/10.1172/JCI112648
- Vishwanath V, Frank KE, Elmets CA, Dauchot PJ, MonnierVM. 1986. Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications. Diabetes35: 916-921. https://doi.org/10.2337/diabetes.35.8.916
- Mullarkey CJ, Edelstein D, Brownlee M. 1990. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 932-939. https://doi.org/10.1016/S0006-291X(05)80875-7
- Makita Z, Bucala R, Rayfield EJ, Friedman EA, KaufmanAM, Korbet SM, Barth RH, Winston JA, Fuh H, ManogueKR. 1994. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 343: 1519-1522. https://doi.org/10.1016/S0140-6736(94)92935-1
- Hammes HP, Alt A, Niwa T, Clausen JT, Bretzel RG,Brownlee M, Schleicher ED. 1999. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia 42: 728-736. https://doi.org/10.1007/s001250051221
- Bucala R, Vlassara H. 1995. Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 26: 875-888. https://doi.org/10.1016/0272-6386(95)90051-9
- Hsieh CL, Lin YC, Ko WS, Peng CH, Huang CN, Peng RY.2005. Inhibitory effect of some selected nutraceutic herbs on LDL glycation induced by glucose and glyoxal. J Ethnopharmacol 102: 357-363. https://doi.org/10.1016/j.jep.2005.06.044
- Ma H, Li SY, Xu P, Babcock SA, Dolence EK, BrownleeM, Li J, Ren J. 2009. Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) upregulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med 13: 1751-1764. https://doi.org/10.1111/j.1582-4934.2008.00547.x
- Sobenin IA, Tertov VV, Koschinsky T, Bunting CE,Slavina ES, Dedov II, Orekhov AN. 1993. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis100: 41-54. https://doi.org/10.1016/0021-9150(93)90066-4
- Magalhaes PM, Appell HJ, Duarte JA. 2008. Involvement of advanced glycation end products in the pathogenesis of diabetic complications: the protective role of regular physical activity. Eur Rev Aging Phys A 5: 17-29. https://doi.org/10.1007/s11556-008-0032-7
- Goh SY, Cooper ME. 2008. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93: 1143-1152. https://doi.org/10.1210/jc.2007-1817
- Lue LF, Walker DG, Brachova L, Beach TG, Rogers J,Schmidt AM, Stern DM, Yan SD. 2001. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. Exp Neurol 171: 29-45. https://doi.org/10.1006/exnr.2001.7732
- Linden E, Cai W, He JC, Xue C, Li Z, Winston J, VlassaraH, Uribarri J. 2008. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin J Am Soc Nephrol 3: 691-698. https://doi.org/10.2215/CJN.04291007
- Lo CY, Li S, Tan D, Pan MH, Sang S, Ho CT. 2006.Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions. Mol Nutr Food Res 50: 1118-1128. https://doi.org/10.1002/mnfr.200600094
- Takada M, Ku Y, Toyama H, Suzuki Y, Kuroda Y. 2002.Suppressive effects of tea polyphenol and conformational changes with receptor for advanced glycation end products (RAGE) expression in human hepatoma cells. Hepatogastroenterology49: 928-931.
- Ahmad MS, Ahmed N. 2006. Antiglycation properties of aged garlic extract: possible role in prevention of diabetic complications. J Nutr 136: 796S-799S. https://doi.org/10.1093/jn/136.3.796S
- Lee HS, Koo YC, Suh HJ, Kim KY, Lee KW. 2010.Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. J Ethnopharmacol 131: 567-574. https://doi.org/10.1016/j.jep.2010.07.039
- Speciale A, Canali R, Chirafisi J, Saija A, Virgili F, Cimino F. 2010. Cyanidin-3-O-glucoside protection against TNF-alpha-induced endothelial dysfunction: involvement of nuclear factor-kappaB signaling. J Agric Food Chem 58:12048-12054. https://doi.org/10.1021/jf1029515
- Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC,Jialal I. 2008. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 93: 578-583. https://doi.org/10.1210/jc.2007-2185
- Basta G, Schmidt AM, De Caterina R. 2004. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res63: 582-592. https://doi.org/10.1016/j.cardiores.2004.05.001
- Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T,Kameda Y. 2000. Immunological evidence that non-carbox-ymethyllysineadvanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Mol Med 6: 114-125.
- Okamoto T, Yamagishi S, Inagaki Y, Amano S, TakeuchiM, Kikuchi S, Ohno S, Yoshimura A. 2002. Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro. Biochem Biophys Res Commun 297:419-424. https://doi.org/10.1016/S0006-291X(02)02218-0
- Niiya Y, Abumiya T, Shichinohe H, Kuroda S, Kikuchi S,Ieko M, Yamagishi S, Takeuchi M, Sato T, Iwasaki Y. 2006.Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species. Brain Res 1108: 179-187. https://doi.org/10.1016/j.brainres.2006.06.038
- Tsouknos A, Nash GB, Rainger GE. 2003. Monocytes initiate a cycle of leukocyte recruitment when cocultured with endothelial cells. Atherosclerosis 170: 49-58. https://doi.org/10.1016/S0021-9150(03)00288-0
- Shibata M, Hariya T, Hatao M, Ashikaga T, Ichikawa P. 1999. Quantitative polymerase chain reaction using an external control mRNA for determination of gene expression in a heterogeneous cell population. Toxicol Sci 49: 290-296. https://doi.org/10.1093/toxsci/49.2.290
-
Tanji K, Mori F, Imaizumi T, Yoshida H, Matsumiya T,Tamo W, Yoshimoto M, Odagiri H, Sasaki M, TakahashiH, Satoh K, Wakabayashi K. 2002. Upregulation of
$\alpha$ -synuclein by lipopolysaccharide and interleukin-1 in human macrophages. Pathology International 52: 572-577. https://doi.org/10.1046/j.1440-1827.2002.01385.x - Heraud JM, Lavergne A, Kazanji M. 2002. Molecular cloning, characterization, and quantification of squirrel monkey (Saimiri sciureus) Th1 and Th2 cytokines. Immunogenetics 54: 20-29. https://doi.org/10.1007/s00251-002-0443-y
- Lee SJ, Lee WK. 2007. Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells. Biol Pharm Bull 30: 1369-1373. https://doi.org/10.1248/bpb.30.1369
- Khalifah RG, Baynes JW, Hudson BG. 1999. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions. Biochem Biophys Res Commun 257: 251-258. https://doi.org/10.1006/bbrc.1999.0371
- Sato T, Shimogaito N, Wu X, Kikuchi S, Yamagishi S,Takeuchi M. 2006. Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease. Am J Alzheimers Dis Other Demen 21: 197-208. https://doi.org/10.1177/1533317506289277
- Munch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ,Vlassara H, Smith MA, Perry G, Riederer P. 1998.Alzheimer's disease-synergistic effects of glucose deficit,oxidative stress and advanced glycation endproducts. J Neural Transm 105 : 439-461. https://doi.org/10.1007/s007020050069
- Matsuse T, Ohga E, Teramoto S, Fukayama M, Nagai R,Horiuchi S, Ouchi Y. 1988. Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis. J Clin Pathol 51: 515-519.
- Dunon D, Piali L, Imhof B. 1996. To stick or not to stick-the new leukocyte homing paradigm. Curr Opin Cell Biol 8:714-723. https://doi.org/10.1016/S0955-0674(96)80114-1